Purdue Pharma Sentenced for Fraud and Kickback Conspiracies — $5 billion in penalties
RedMap Risk Score
90/100
CRITICAL RISK
Risk Signal Summary
Purdue Pharma LP was sentenced in federal court in Newark, NJ, and ordered to pay over $5 billion for fraud and kickback conspiracies related to its opioid products. The company illegally marketed opioids and misled the DEA from 2007 to 2017.
Why This Matters
Governance and compliance anomalies in organizations managing public funds or charitable assets directly affect donors, beneficiaries, and taxpayers. The risk indicators identified in this report warrant further scrutiny by regulators, donors, and oversight bodies.
Create a free account
Unlimited access to all articles · No daily limit
No credit card · Instant access
Multiple related entities detected
🔒 Purdue Pharma LP has potential risk indicators with connected organizations. Unlock full network analysis.
Sign up free to unlock →Disclaimer: This report identifies risk indicators and unusual financial patterns based on publicly available IRS Form 990 data and government enforcement records. It does not assert fraud, criminal conduct, or legal violations. All findings are for informational purposes only and should not be construed as legal or financial advice.
Share this finding
You just analyzed Purdue Pharma LP — Risk Score 90/100, $5.0B involved. Share this with your network.
Post text is pre-formatted for maximum reach — you can edit before posting.
Discover more risk signals across the USA.